HOXA5 acts directly downstream of retinoic acid receptor β and contributes to retinoic acid-induced apoptosis and growth inhibition

Hexin Chen, Huiping Zhang, Jishin Lee, Xiaohui Liang, Xinyan Wu, Tao Zhu, Pang Kuo Lo, Xiaokun Zhang, Saraswati Sukumar

Research output: Contribution to journalArticle

Abstract

The promise of retinoids as chemopreventive agents in breast cancer is based on the differentiation and apoptosis induced upon their binding to the retinoic acid (RA) receptor β (RARβ). We have previously shown that HOXA5 induces apoptosis in breast cancer cells. In this study, we investigated whether RA/RARβ and HOXA5 actions intersect to induce apoptosis and differentiation in breast cancer cells. We found that HOXA5 expression can be induced by RA only in RARβ-positive breast cancer cells. We have, for the first time, identified the RA response element in HOXA5, which was found to be located in the 3′ end of the gene. Chromatin immunoprecipitation assays showed that RARβ binds directly to this region in vivo. Overexpression of RARβ strongly enhances RA responsiveness, and knocking down RARβ expression abolishes RA-mediated induction of HOXA5 expression in breast cancer cells. In addition, there is coordinated loss of both HOXA5 and RARβ expression during neoplastic transformation and progression in the breast epithelial cell model, MCF10A. Knockdown of HOXA5 expression partially abrogates retinoid-induced apoptosis and promotes cell survival upon RA treatment. These results strongly suggest that HOXA5 acts directly downstream of RARβ and may contribute to retinoid-induced anticancer and chemopreventive effects.

Original languageEnglish (US)
Pages (from-to)8007-8013
Number of pages7
JournalCancer Research
Volume67
Issue number17
DOIs
StatePublished - Sep 1 2007

Fingerprint

Retinoic Acid Receptors
Tretinoin
Apoptosis
Breast Neoplasms
Retinoids
Growth
Chromatin Immunoprecipitation
Response Elements
Cell Survival
Breast
Epithelial Cells
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

HOXA5 acts directly downstream of retinoic acid receptor β and contributes to retinoic acid-induced apoptosis and growth inhibition. / Chen, Hexin; Zhang, Huiping; Lee, Jishin; Liang, Xiaohui; Wu, Xinyan; Zhu, Tao; Lo, Pang Kuo; Zhang, Xiaokun; Sukumar, Saraswati.

In: Cancer Research, Vol. 67, No. 17, 01.09.2007, p. 8007-8013.

Research output: Contribution to journalArticle

Chen, Hexin ; Zhang, Huiping ; Lee, Jishin ; Liang, Xiaohui ; Wu, Xinyan ; Zhu, Tao ; Lo, Pang Kuo ; Zhang, Xiaokun ; Sukumar, Saraswati. / HOXA5 acts directly downstream of retinoic acid receptor β and contributes to retinoic acid-induced apoptosis and growth inhibition. In: Cancer Research. 2007 ; Vol. 67, No. 17. pp. 8007-8013.
@article{0eba24b1f703439096f3d9e0c5ffa343,
title = "HOXA5 acts directly downstream of retinoic acid receptor β and contributes to retinoic acid-induced apoptosis and growth inhibition",
abstract = "The promise of retinoids as chemopreventive agents in breast cancer is based on the differentiation and apoptosis induced upon their binding to the retinoic acid (RA) receptor β (RARβ). We have previously shown that HOXA5 induces apoptosis in breast cancer cells. In this study, we investigated whether RA/RARβ and HOXA5 actions intersect to induce apoptosis and differentiation in breast cancer cells. We found that HOXA5 expression can be induced by RA only in RARβ-positive breast cancer cells. We have, for the first time, identified the RA response element in HOXA5, which was found to be located in the 3′ end of the gene. Chromatin immunoprecipitation assays showed that RARβ binds directly to this region in vivo. Overexpression of RARβ strongly enhances RA responsiveness, and knocking down RARβ expression abolishes RA-mediated induction of HOXA5 expression in breast cancer cells. In addition, there is coordinated loss of both HOXA5 and RARβ expression during neoplastic transformation and progression in the breast epithelial cell model, MCF10A. Knockdown of HOXA5 expression partially abrogates retinoid-induced apoptosis and promotes cell survival upon RA treatment. These results strongly suggest that HOXA5 acts directly downstream of RARβ and may contribute to retinoid-induced anticancer and chemopreventive effects.",
author = "Hexin Chen and Huiping Zhang and Jishin Lee and Xiaohui Liang and Xinyan Wu and Tao Zhu and Lo, {Pang Kuo} and Xiaokun Zhang and Saraswati Sukumar",
year = "2007",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-07-1405",
language = "English (US)",
volume = "67",
pages = "8007--8013",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - HOXA5 acts directly downstream of retinoic acid receptor β and contributes to retinoic acid-induced apoptosis and growth inhibition

AU - Chen, Hexin

AU - Zhang, Huiping

AU - Lee, Jishin

AU - Liang, Xiaohui

AU - Wu, Xinyan

AU - Zhu, Tao

AU - Lo, Pang Kuo

AU - Zhang, Xiaokun

AU - Sukumar, Saraswati

PY - 2007/9/1

Y1 - 2007/9/1

N2 - The promise of retinoids as chemopreventive agents in breast cancer is based on the differentiation and apoptosis induced upon their binding to the retinoic acid (RA) receptor β (RARβ). We have previously shown that HOXA5 induces apoptosis in breast cancer cells. In this study, we investigated whether RA/RARβ and HOXA5 actions intersect to induce apoptosis and differentiation in breast cancer cells. We found that HOXA5 expression can be induced by RA only in RARβ-positive breast cancer cells. We have, for the first time, identified the RA response element in HOXA5, which was found to be located in the 3′ end of the gene. Chromatin immunoprecipitation assays showed that RARβ binds directly to this region in vivo. Overexpression of RARβ strongly enhances RA responsiveness, and knocking down RARβ expression abolishes RA-mediated induction of HOXA5 expression in breast cancer cells. In addition, there is coordinated loss of both HOXA5 and RARβ expression during neoplastic transformation and progression in the breast epithelial cell model, MCF10A. Knockdown of HOXA5 expression partially abrogates retinoid-induced apoptosis and promotes cell survival upon RA treatment. These results strongly suggest that HOXA5 acts directly downstream of RARβ and may contribute to retinoid-induced anticancer and chemopreventive effects.

AB - The promise of retinoids as chemopreventive agents in breast cancer is based on the differentiation and apoptosis induced upon their binding to the retinoic acid (RA) receptor β (RARβ). We have previously shown that HOXA5 induces apoptosis in breast cancer cells. In this study, we investigated whether RA/RARβ and HOXA5 actions intersect to induce apoptosis and differentiation in breast cancer cells. We found that HOXA5 expression can be induced by RA only in RARβ-positive breast cancer cells. We have, for the first time, identified the RA response element in HOXA5, which was found to be located in the 3′ end of the gene. Chromatin immunoprecipitation assays showed that RARβ binds directly to this region in vivo. Overexpression of RARβ strongly enhances RA responsiveness, and knocking down RARβ expression abolishes RA-mediated induction of HOXA5 expression in breast cancer cells. In addition, there is coordinated loss of both HOXA5 and RARβ expression during neoplastic transformation and progression in the breast epithelial cell model, MCF10A. Knockdown of HOXA5 expression partially abrogates retinoid-induced apoptosis and promotes cell survival upon RA treatment. These results strongly suggest that HOXA5 acts directly downstream of RARβ and may contribute to retinoid-induced anticancer and chemopreventive effects.

UR - http://www.scopus.com/inward/record.url?scp=34548565802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548565802&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-1405

DO - 10.1158/0008-5472.CAN-07-1405

M3 - Article

VL - 67

SP - 8007

EP - 8013

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -